Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
Article number100337
JournalEClinicalMedicine
Volume22
ISSN2589-5370
DOIs
Publication statusPublished - 2020

ID: 250166452